期刊文献+

儿茶酚胺抑素与原发性高血压左室肥厚的关系及培哚普利的干预疗效 被引量:5

原文传递
导出
摘要 目的 观察原发性高血压患者血浆儿茶酚胺抑素(CST)、心房利钠尿肽(ANP)和脑利钠尿肽(BNP)水平,探讨CST与ANP、BNP和原发性高血压左室质量指数(LVMI)关系及培哚普利干预的疗效.方法 收取68例原发性高血压患者,左室肥厚(LVH)组28例,无左心室肥厚(NLVH)组40例,健康体检者30例作为对照组.检测三组血浆CST、ANP及BNP水平,心脏彩超测量左室壁厚度及各心腔径等指标.予原发性高血压患者培哚普利干预,随访2个月后复测上述各指标.结果 CST与BNP、ANP、LVMI均呈正相关(P<0.05),多元线性回归分析显示,LVMI与CST独立相关;培哚普利干预治疗后血浆CST水平显著下降,差异有统计学意义(P<0.05).结论 CST可能成为原发性高血压及左室肥厚的一个独立预测指标;培哚普利药既可降压,又能降低儿茶酚胺抑素水平.
作者 孔涛 贺立新
出处 《中国医师杂志》 CAS 2016年第5期773-775,共3页 Journal of Chinese Physician
  • 相关文献

参考文献13

  • 1Maneia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the Management of Arterial Hypertension; The Task Force for the Management of ArterialHypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) [J]. J Hypertens, 2007 ,25(6) :1105-1187.
  • 2Pouher NR, Prabhakaran D, Caulfield M. Hypertension [ J]. Lancet, 2015, 386 (9995) : 801-812. DOI: 10. 1016/S0140- 6736( 14)61468-9. '.
  • 3Cheng TH, Shih NL, Chen CH, et al. Role of mitogen-activated protein kinase pathway in reactive oxygen species-mediated endo- thelin-l-inducedbeta-myosin heavy chain gene expression and car- diomyocyte hypertrophy[J]. J Biomed Sci, 2005, 12 ( 1 ) : 123- 133. DOI: 10. 1007/s11373-004-8168-6.
  • 4de Carvalho Frimm C, Koike MK, Cari M. Subendoeardial fibro-sis in remote myocardium results from reduction of coronary driving pressure during acute infarction in rats [ J]. Arq Brag Cardiol, 2003, 80 ( 5 ): 509-520. DOI: 10. 1590/s0066- 782x2003000500004.
  • 5Rao F, Wen G, Gayen JR, et al. Catecholamine release-inhibitory peptide catestatin ( chromogranin A( 352-372 ) ) : naturally occur- ring amino acid variant Gly364Ser causes profound changes in hu- man autonomic activity and alters risk for hypertension [ J]. Circu- lation ,2007,115 ( 17 ) : 2271-2281. DOI : 10.1161/circulationa- ha. 106. 628859.
  • 6Mazza R, Gattuso A, Mannarino C, etM. Catestatin ( chromogranin A344-364) is a novel cardiouppresive agent: inhibition of iso- proterenol and endothelin signaling in the frog heart [ J ]. Am J Physiol Heart Circ Physiol, 2008 ,295 ( 1 ) : Hl13-H122. :DOI: 10.1152/ajpheart. 00172; 2008.
  • 7Liu Y, Zhao W, Gao W. GW26-e1569 Relationship between cat- estatin and heart rate recovery after acute myocardial infarction [ J ]. J Am Coil Cardiol, 2015, 66 (16) : C231-C232.
  • 8Pei Z, Ma D, Ji L, et al. Usefulness of catestatin to predict malig- nant arrhythmia in patients with acute myocardial infarction [ J ]. Peptides, 2014, 55 (5):131-135. DOI: 10. 1016/j. peptides. 2014.02. 016.
  • 9杜振兰,张海东.原发性高血压患者左室构型与儿茶酚胺的关系[J].中国组织工程研究与临床康复,2007,11(38):7566-7568. 被引量:3
  • 10叶小巾,丁文惠,孟磊.儿茶酚抑素在心血管系统的作用[J].医学研究杂志,2012,41(1):6-9. 被引量:9

二级参考文献51

  • 1邓珍华,苏静,王琴双.原发性高血压左室构型的研究[J].内蒙古医学杂志,2004,36(11):887-889. 被引量:1
  • 2孙琪,徐泽昌,张桂珍,陈念,刘星,李鲁光.原发性高血压向心性重塑患者左心构型和功能的变化[J].中华超声影像学杂志,2005,14(2):99-101. 被引量:2
  • 3薛迎生,陆弋,方崇峰,卢振,唐礼江.儿茶酚胺心肌病1例及文献复习[J].浙江实用医学,2005,10(2):143-144. 被引量:2
  • 4彭应心,黄希正,王振起,王进华,张新智.高血压病左室肥厚的室性心律失常与心室晚电位关系的探讨[J].中华心血管病杂志,1994,22(2):96-98. 被引量:31
  • 5Pieroni M,et al.Myocardial production of chromogranin A in human heart:a new regulatory peptide of cardiac function[J].Eur Heart J,2007,28(9):1117-1127.
  • 6Jansson AM,et al.Prognostic value of circulating chromogranin A levels in acute coronary syndromes[J].Eur Heart J,2009,30(1):25-32.
  • 7Ceconi C,et al.Chromogranin A in heart failure:a novel neurohumoral factor and a predictor for mortality[J].Eur Heart J,2002,23(12):967-974.
  • 8Rao F,et al.Catecholamine release-inhibitory peptide catestatin[chromogranin A (352-372)]:naturally occurring amino acid variant Gly364Ser causes profound changes in human autonomic activity and alters risk for hypertension[J].Circulation,2007,115 (17):2271-2281.
  • 9Tsigelny I,et al.Mechanism of action of chromogranin A on catecholamine release:molecular modeling of the catestatin region reveals a beta-strand/loop/beta-strand structure secured by hydrophobic interactions and predictive of activity[J].Regul Pept,1998,77 (1-3):43-53.
  • 10Mahata SK,et al.Primary structure and function of the catecholamine release inhibitory peptide catestatin[chromogranin A (344-364)]:identification of amino acid residues crucial for activity[J].Mol Endocrinol,2000,14(10):1525-1535.

共引文献26

同被引文献59

引证文献5

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部